Pyridostigmine
- Generic Name
- Pyridostigmine
- Brand Names
- Mestinon, Regonol
- Drug Type
- Small Molecule
- Chemical Formula
- C9H13N2O2
- CAS Number
- 155-97-5
- Unique Ingredient Identifier
- 19QM69HH21
- Background
Myasthenia gravis is an autoimmune disease involving dysfunction at the neuromuscular junction, most commonly due to autoantibodies directed against the acetylcholine receptor (AChR), which results in muscle tone loss, muscle weakness, and fatigue. Acetylcholinesterase inhibitors have been the symptomatic treatment of choice in myasthenia gravis since the 19...
- Indication
Pyridostigmine is indicated for the treatment of myasthenia gravis. When administered intravenously, it is indicated for the reversal or antagonism of the neuromuscular blocking effects of nondepolarizing muscle relaxants.
...
- Associated Conditions
- Congenital Myasthenia (CM), Constipation, Myasthenia Gravis, Neuromuscular Blockade, Post-Poliomyelitis Syndrome, Orthostatic syncope, Soman nerve gas poisoning
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath